# ENDRA Life Sciences Inc.: Form DEF 14A, filed Oct 17, 2022

- Company: [ENDRA Life Sciences Inc.](/companies/ndra.md) (CIK 1681682)
- Form: DEF 14A
- Filed: 2022-10-17
- Accepted by EDGAR: Oct 17, 2022, 16:15 ET
- Period: 2022-11-29
- Accession: 0001140361-22-037399
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1681682/000114036122037399/ny20005397x2_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1681682/000114036122037399/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1681682/000114036122037399/ny20005397x2_def14a.htm

Filed Oct 17, 2022.
Source: SEC EDGAR, the filing index for accession 0001140361-22-037399. Last ingested by Listed: Nov 10, 2026, 17:03 ET. No prices; not investment advice.
